Merial exclusive marketing and distribution rights for SurBred 15
Company: Riot
The claim, verbatim
Merial Limited has exclusive rights to market and distribute SurBred 15 worldwide once the product is fully developed
Source (primary)
Riot SB-2 filed 2004-09-14 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “Merial Limited, a joint venture of Merck and Aventis, has the exclusive right to market and distribute SurBred 15 worldwide, once the product is fully developed.”
How we checked this
Checked on September 30, 2026. The cited source supports every part of this claim.
The filing states that Merial Limited holds exclusive worldwide marketing and distribution rights to SurBred 15 once the product is fully developed.
Confirmed in the source:
- Merial Limited has the exclusive right to market and distribute SurBred 15 worldwide
- This right applies once SurBred 15 is fully developed
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1167419/000107997304000468/aspenbio_sb2.txt) in full (272,234 characters, retrieved September 27, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Riot SB-2 filed 2004-09-14
Quote: “Merial Limited, a joint venture of Merck and Aventis, has the exclusive right to market and distribute SurBred 15 worldwide, once the product is fully developed.”